Literature DB >> 17938849

Are maximum P wave duration and P wave dispersion a marker of target organ damage in the hypertensive population?

Necati Dagli1, Ilgin Karaca, Mustafa Yavuzkir, Mehmet Balin, Nadi Arslan.   

Abstract

BACKGROUND: High blood pressure, left ventricular hypertrophy and diastolic dysfunction may cause hemodynamic and morphological changes in the left atrium, consequently instability and heterogeneity in atrial conduction. This is seen as an increase in maximum P wave duration (P(max)) and P wave dispersion (PD) on the electrocardiogram (ECG). P wave dispersion on ECG has been encountered as a risk factor for atrial fibrillation (AF). The aim of this study is to examine whether PD and P(max) can be used as a non-invasive marker of target organ damage (LVH and diastolic dysfunction) in a hypertensive population.
MATERIAL AND METHODS: The study registered a total of 120 cases (mean age 46.9 +/- 10.6 years; 58 [48.3%] males and 62 [51.7%] females), of whom 60 were patients diagnosed as essential hypertension (group 1), and 60 were healthy individuals, who constituted the control group (group 2). Systolic and diastolic functions of all cases were evaluated by echocardiography, and maximum P wave duration (P(max)), and PD was calculated.
RESULTS: Maximum P wave duration was 91.6 +/- 10.2 ms in group 1, and 64 +/- 10.2 ms in group 2 (p < 0.01), while PD was 56.1 +/- 5.8 ms in group 1, and 30.3 +/- 6.6 ms in group 2 (p < 0.01). Blood pressure, left atrium diameter, DT, IVRT, and E/A ratio, as well as left ventricular mass index increased markedly in group 1.
CONCLUSION: High blood pressure, LVH, diastolic dysfunction and increased left atrium diameter and volume shows parallelism in hypertensive cases. These physiopathological changes may cause different and heterogeneous atrial electrical conduction. This led to a marked increase in P(max) and PD in our cases. Thus, the results support the hypothesis that PD can be used as a non-invasive marker of target organ damage (LVH and LV diastolic dysfunction) in the hypertension population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17938849     DOI: 10.1007/s00392-007-0587-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  29 in total

1.  Regression of left ventricular hypertrophy and improved prognosis: some hope now . . . or hype?

Authors:  G Y Lip
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

2.  Left atrial remodelling after short duration atrial fibrillation in hypertrophic hearts.

Authors:  A V Mattioli; S Bonatti; D Monopoli; M Zennaro; G Mattioli
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

3.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

4.  ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography.

Authors:  M D Cheitlin; J S Alpert; W F Armstrong; G P Aurigemma; G A Beller; F Z Bierman; T W Davidson; J L Davis; P S Douglas; L D Gillam; R P Lewis; A S Pearlman; J T Philbrick; P M Shah; R G Williams; J L Ritchie; K A Eagle; T J Gardner; A Garson; R J Gibbons; R A O'Rourke; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

5.  Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension.

Authors:  B C Aeschbacher; D Hutter; J Fuhrer; P Weidmann; E Delacrétaz; Y Allemann
Journal:  Am J Hypertens       Date:  2001-02       Impact factor: 2.689

6.  Influence of blood pressure on left atrial size. The Framingham Heart Study.

Authors:  S M Vaziri; M G Larson; M S Lauer; E J Benjamin; D Levy
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

7.  Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis.

Authors:  Ali Riza Erbay; Hasan Turhan; Ayse Saatci Yasar; Asuman Bicer; Kubilay Senen; Hatice Sasmaz; Irfan Sabah; Ertan Yetkin
Journal:  Int J Cardiol       Date:  2005-06-22       Impact factor: 4.164

8.  The signal-averaged P-wave duration is longer in hypertensive patients with history of paroxysmal atrial fibrillation as compared to those without.

Authors:  Kudret Aytemir; Basri Amasyali; Gulcan Abali; Sedat Kose; Ayhan Kilic; Orhan Onalan; Lale Tokgozoglu; Giray Kabakci; Hilmi Ozkutlu; Nasih Nazli; Ersoy Isik; Ali Oto
Journal:  Int J Cardiol       Date:  2004-12-15       Impact factor: 4.164

9.  Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients.

Authors:  M Kelm; S Schäfer; S Mingers; M Heydthausen; M Vogt; W Motz; B E Strauer
Journal:  J Hypertens       Date:  1996-11       Impact factor: 4.844

10.  P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy.

Authors:  Kubilay Senen; Hasan Turhan; Ali Riza Erbay; Nurcan Basar; Ayse Saatci Yasar; Onur Sahin; Ertan Yetkin
Journal:  Eur J Heart Fail       Date:  2004-08       Impact factor: 15.534

View more
  20 in total

1.  Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics.

Authors:  Udi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  P-wave morphologic characteristics predict cardiovascular events in a community-dwelling population.

Authors:  Tomoyuki Kabutoya; Shizukiyo Ishikawa; Joji Ishikawa; Satoshi Hoshide; Kazuomi Kario
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

3.  Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease.

Authors:  Ilker Murat Caglar; Tolga Dasli; Fatma Nihan Turhan Caglar; Mehmet Kamil Teber; Murat Ugurlucan; Gokhan Ozmen
Journal:  Clin Res Cardiol       Date:  2012-03-06       Impact factor: 5.460

4.  P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).

Authors:  Jared W Magnani; Michael J Mazzini; Lisa M Sullivan; MaryAnn Williamson; Patrick T Ellinor; Emelia J Benjamin
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-01       Impact factor: 1.468

5.  Relationship between atrial conduction delay and obstructive sleep apnea.

Authors:  Ken-Ichi Maeno; Takatoshi Kasai; Satoshi Kasagi; Fusae Kawana; Sugao Ishiwata; Minoru Ohno; Tetsu Yamaguchi; Koji Narui
Journal:  Heart Vessels       Date:  2012-09-14       Impact factor: 2.037

6.  P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey.

Authors:  Jared W Magnani; Eiran Z Gorodeski; Victor M Johnson; Lisa M Sullivan; Naomi M Hamburg; Emelia J Benjamin; Patrick T Ellinor
Journal:  Heart Rhythm       Date:  2010-09-22       Impact factor: 6.343

7.  P-wave indices: derivation of reference values from the Framingham Heart Study.

Authors:  Jared W Magnani; Victor M Johnson; Lisa M Sullivan; Steven A Lubitz; Renate B Schnabel; Patrick T Ellinor; Emelia J Benjamin
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

8.  Association of blood pressure and aortic distensibility with P wave indices and PR interval: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Alvaro Alonso; Elsayed Z Soliman; Lin Y Chen; David A Bluemke; Susan R Heckbert
Journal:  J Electrocardiol       Date:  2013-02-26       Impact factor: 1.438

Review 9.  Electrocardiogram (ECG) for the Prediction of Incident Atrial Fibrillation: An Overview.

Authors:  Yoshifusa Aizawa; Hiroshi Watanabe; Ken Okumura
Journal:  J Atr Fibrillation       Date:  2017-12-31

Review 10.  P wave indices: current status and future directions in epidemiology, clinical, and research applications.

Authors:  Jared W Magnani; Mary Ann Williamson; Patrick T Ellinor; Kevin M Monahan; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.